Researchers watch and learn: no new treatment for rare sarcoma

NCT ID NCT03099681

Recruiting now Knowledge-focused Sponsor: Italian Sarcoma Group Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study is observing 100 people with epithelioid sarcoma, a rare cancer. Researchers will track what treatments patients receive and how they respond. The goal is to better understand the disease and current care, not to test a new drug.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EPITHELIOID SARCOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epithelioid sarcoma sarcoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPITHELIOID SARCOMA

Contacts and locations

Locations

Azienda Ospedaliera Universitaria Paolo Giaccone
RECRUITING

Palermo, PA, 90127, Italy
Campus Biomedico
RECRUITING

Roma, Italy
Fondazione IRCCS INT Milano
RECRUITING

Milan, Italy
Fondazione del Piemonte per l'Oncologia IRCC Candiolo
RECRUITING

Candiolo, Torino, 10060, Italy
Irccs Istituto Oncologico Veneto (Iov)
RECRUITING

Padova, Italy
Istituti Fisioterapici Ospitalieri di Roma
RECRUITING

Roma, Italy
Istituto Clinico Humanitas
RECRUITING

Rozzano, MI, 20089, Italy
Istituto Europeo di Oncologia
RECRUITING

Milan, MI, 20141, Italy
Istituto Ortopedico Rizzoli - Unit of Chemotherapy of Muscoloskeletal Tumors
RECRUITING

Bologna, 40136, Italy
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST
RECRUITING

Meldola, FC, Italy
Ospedale Misericordia e Dolce Ist. Toscano Tumori, Az. USL4
RECRUITING

Prato, 59100, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.